Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 766
1.
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UILJ, UL, UM, UPCLJ, UPUK, ZAGLJ, ZRSKP

PDF
2.
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
3.
  • Pembrolizumab versus paclit... Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
    Fuchs, Charles S.; Özgüroğlu, Mustafa; Bang, Yung-Jue ... Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 01/2022, Letnik: 25, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Background In the phase 3 KEYNOTE-061 study (cutoff: 10/26/2017), pembrolizumab did not significantly prolong OS vs paclitaxel as second-line (2L) therapy in PD-L1 combined positive score (CPS) ≥ 1 ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
4.
  • Comprehensive registry of e... Comprehensive registry of esophageal cancer in Japan, 2013
    Watanabe, Masayuki; Tachimori, Yuji; Oyama, Tsuneo ... Esophagus : official journal of the Japan Esophageal Society, 01/2021, Letnik: 18, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Background Esophageal cancer is the eighth most common cause of cancer mortality in Japan. More than 11,000 people had died from esophageal cancer in 2018. The Japan Esophageal Society has collected ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
5.
  • Randomized Phase III KEYNOT... Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
    Kojima, Takashi; Shah, Manish A; Muro, Kei ... Journal of clinical oncology, 12/2020, Letnik: 38, Številka: 35
    Journal Article
    Recenzirano
    Odprti dostop

    Patients with advanced esophageal cancer have a poor prognosis and limited treatment options after first-line chemotherapy. In this open-label, phase III study, we randomly assigned (1:1) 628 ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK
6.
  • A phase 3 study of nivoluma... A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
    Chen, Li-Tzong; Satoh, Taroh; Ryu, Min-Hee ... Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 05/2020, Letnik: 23, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Background Nivolumab showed improvement in overall survival (OS) in ATTRACTION-2, the first phase 3 study in patients with gastric/gastroesophageal junction (G/GEJ) cancer treated with ≥ 2 ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
7.
  • A multicenter, open-label, ... A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
    Hasegawa, Hirotaka; Shitara, Kohei; Takiguchi, Shuji ... Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 05/2022, Letnik: 25, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    Background Nivolumab monotherapy has demonstrated superior efficacy in advanced unresectable gastric cancer (GC), but its impact on resectable GC remains unknown. This phase I study aimed to evaluate ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
8.
  • Japanese Society for Cancer... Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
    Hashiguchi, Yojiro; Muro, Kei; Saito, Yutaka ... International journal of clinical oncology, 01/2020, Letnik: 25, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, ...
Celotno besedilo
Dostopno za: EMUNI, FIS, FZAB, GEOZS, GIS, IJS, IMTLJ, KILJ, KISLJ, MFDPS, NLZOH, NUK, OBVAL, OILJ, PNG, SAZU, SBCE, SBJE, SBMB, SBNM, UKNU, UL, UM, UPUK, VKSCE, ZAGLJ

PDF
9.
  • Pembrolizumab for patients ... Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
    Muro, Kei, Dr; Chung, Hyun Cheol, Prof; Shankaran, Veena, MD ... The lancet oncology, 06/2016, Letnik: 17, Številka: 6
    Journal Article
    Recenzirano

    Summary Background Expression of PD-L1 has been shown to be upregulated in some patients with gastric cancer. As part of the phase 1b KEYNOTE-012 study, we aimed to assess the safety and activity of ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP
10.
  • Nivolumab treatment for oes... Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
    Kudo, Toshihiro, PhD; Hamamoto, Yasuo, Dr; Kato, Ken, PhD ... The lancet oncology, 05/2017, Letnik: 18, Številka: 5
    Journal Article
    Recenzirano

    Summary Background Nivolumab is a human monoclonal IgG4 antibody that inhibits programmed cell death protein 1 (PD-1) expressed on activated T cells. We investigated the safety and activity of ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK, ZRSKP
1 2 3 4 5
zadetkov: 766

Nalaganje filtrov